Recent Advances in 3D Bioprinting for Drug Delivery and Tissue Engineering
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Pharmaceutical Technology, Manufacturing and Devices".
Deadline for manuscript submissions: 25 February 2025 | Viewed by 335
Special Issue Editor
Interests: bone tissue engineering; vascular graft; cell and drug deliveries; injectable hydrogels for soft and hard tissue engineering; biomaterials; medical devices; microfluidic
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
With the advent of a new generation of biomaterials and manufacturing techniques, it is possible to overcome the challenges associated with the development of drugs, drug delivery systems, and medical devices and personalized medicine. With the advent of new technologies, such as 3D printing, hospitals are able to utilize these techniques for a variety of purposes. Moreover, 3D printing can be used to produce customized medical devices or devices adapted to the individual patient's needs. This Special Issue highlights the publication of papers on various areas of research, including drug delivery using bioinks, medical devices such as vascular grafts, durable implants, surgical meshes, microneedles, wound healing, and hemostatic agents using additive manufacturing (e.g., 3D printing, 4D printing, and bioprinting).
This Special Issue aims to encourage the submission of recent original research articles and reviews on the fabrication of novel DDSs and medical devices using innovative 3D printing technologies, as well as bioprinting applications for pharmaceuticals and tissue engineering (e.g., wound healing).
Dr. Jhaleh Amirian
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- 3D printing
- bioink
- drug delivery system
- personalized medicine
- medical devices
- tissue engineering
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
